6290EGP
- Active ingredient
- temsirolimus
- Strength
- 30mg/1.2ml
- Form
- vial
- Manufacturer
- pierre - fabre france > pfizer
- Route
- injection
Uses
Antineoplastic agent used in advanced renal cell carcinoma and selected cancers.
Do not use if
Hypersensitivity to temsirolimus, sirolimus, or formulation components.
Side effects
Rash, anemia, hyperglycemia, infections, and fatigue may occur.
Warnings
Monitor blood counts, glucose levels, and infection risk.
How it works
mTOR inhibitor that suppresses tumor cell growth and proliferation.
Storage
Store according to product labeling.